Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
LGVN | Longeveron Inc. | Chief Executive Officer | $572K | Oct 1, 2024 | ||
AKTX | Akari Therapeutics Plc | Director | Jun 28, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|